Industrial Large Scale of Suspension Culture of Insect Cells

António Roldão, Manon Cox, Paula Alves, Manuel Carrondo, Tiago Vicente

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Since the first reported work on insect cells by Goldschmidt in 1915, more than 600 insect cell lines have been established. With the generation of the first recombinant baculovirus in the late 1980s, the application of insect cell lines for expression of heterologous gene products grew exponentially. Today, the insect cell-baculovirus system is well accepted as a universal manufacturing platform, as demonstrated by the number of approved veterinary and human vaccines. In addition, insect cells are an inexpensive, safe and efficient alternative to human and animal-derived cell lines for studying host-pathogen interactions, cell metabolism, or cellular and humoral immunity, as well as for the production of gene delivery vectors for human gene therapy, for example, modified baculoviruses and mammalian vectors generated via adeno-associated virus. In the longer term, the comprehensive understanding of the regulation and fate of insect stem cells may enable the use of insect cells as a model organism for the development of novel therapies for human diseases. In this chapter, the potential of insect cells is thoroughly discussed, from the basic concepts in cell culture to their requirements in terms of up- and down-stream processing as well as the regulatory hurdles.

Original languageEnglish
Title of host publicationIndustrial Scale Suspension Culture of Living Cells
PublisherWiley/Blackwell
Pages348-389
Number of pages42
ISBN (Electronic)978-352768332-1
ISBN (Print)978-352733547-3
DOIs
Publication statusPublished - 4 Aug 2014

Fingerprint

Insects
Suspensions
Cell Culture Techniques
Cells
Genes
Baculoviridae
Gene therapy
Pathogens
Stem cells
Viruses
Cell culture
Metabolism
Animals
Vaccines
Cell Line
Processing
Host-Pathogen Interactions
Dependovirus
Humoral Immunity
Cellular Immunity

Keywords

  • Biomedicine and biopharmaceuticals
  • Bioreactor design
  • Expression system
  • Insect cells
  • Metabolism
  • Up- and down-stream processing

Cite this

Roldão, A., Cox, M., Alves, P., Carrondo, M., & Vicente, T. (2014). Industrial Large Scale of Suspension Culture of Insect Cells. In Industrial Scale Suspension Culture of Living Cells (pp. 348-389). Wiley/Blackwell. https://doi.org/10.1002/9783527683321.ch10
Roldão, António ; Cox, Manon ; Alves, Paula ; Carrondo, Manuel ; Vicente, Tiago. / Industrial Large Scale of Suspension Culture of Insect Cells. Industrial Scale Suspension Culture of Living Cells. Wiley/Blackwell, 2014. pp. 348-389
@inbook{a31a98cf3404444a8507f22d1baf8bda,
title = "Industrial Large Scale of Suspension Culture of Insect Cells",
abstract = "Since the first reported work on insect cells by Goldschmidt in 1915, more than 600 insect cell lines have been established. With the generation of the first recombinant baculovirus in the late 1980s, the application of insect cell lines for expression of heterologous gene products grew exponentially. Today, the insect cell-baculovirus system is well accepted as a universal manufacturing platform, as demonstrated by the number of approved veterinary and human vaccines. In addition, insect cells are an inexpensive, safe and efficient alternative to human and animal-derived cell lines for studying host-pathogen interactions, cell metabolism, or cellular and humoral immunity, as well as for the production of gene delivery vectors for human gene therapy, for example, modified baculoviruses and mammalian vectors generated via adeno-associated virus. In the longer term, the comprehensive understanding of the regulation and fate of insect stem cells may enable the use of insect cells as a model organism for the development of novel therapies for human diseases. In this chapter, the potential of insect cells is thoroughly discussed, from the basic concepts in cell culture to their requirements in terms of up- and down-stream processing as well as the regulatory hurdles.",
keywords = "Biomedicine and biopharmaceuticals, Bioreactor design, Expression system, Insect cells, Metabolism, Up- and down-stream processing",
author = "Ant{\'o}nio Rold{\~a}o and Manon Cox and Paula Alves and Manuel Carrondo and Tiago Vicente",
note = "sem pdf.",
year = "2014",
month = "8",
day = "4",
doi = "10.1002/9783527683321.ch10",
language = "English",
isbn = "978-352733547-3",
pages = "348--389",
booktitle = "Industrial Scale Suspension Culture of Living Cells",
publisher = "Wiley/Blackwell",

}

Roldão, A, Cox, M, Alves, P, Carrondo, M & Vicente, T 2014, Industrial Large Scale of Suspension Culture of Insect Cells. in Industrial Scale Suspension Culture of Living Cells. Wiley/Blackwell, pp. 348-389. https://doi.org/10.1002/9783527683321.ch10

Industrial Large Scale of Suspension Culture of Insect Cells. / Roldão, António; Cox, Manon; Alves, Paula; Carrondo, Manuel; Vicente, Tiago.

Industrial Scale Suspension Culture of Living Cells. Wiley/Blackwell, 2014. p. 348-389.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Industrial Large Scale of Suspension Culture of Insect Cells

AU - Roldão, António

AU - Cox, Manon

AU - Alves, Paula

AU - Carrondo, Manuel

AU - Vicente, Tiago

N1 - sem pdf.

PY - 2014/8/4

Y1 - 2014/8/4

N2 - Since the first reported work on insect cells by Goldschmidt in 1915, more than 600 insect cell lines have been established. With the generation of the first recombinant baculovirus in the late 1980s, the application of insect cell lines for expression of heterologous gene products grew exponentially. Today, the insect cell-baculovirus system is well accepted as a universal manufacturing platform, as demonstrated by the number of approved veterinary and human vaccines. In addition, insect cells are an inexpensive, safe and efficient alternative to human and animal-derived cell lines for studying host-pathogen interactions, cell metabolism, or cellular and humoral immunity, as well as for the production of gene delivery vectors for human gene therapy, for example, modified baculoviruses and mammalian vectors generated via adeno-associated virus. In the longer term, the comprehensive understanding of the regulation and fate of insect stem cells may enable the use of insect cells as a model organism for the development of novel therapies for human diseases. In this chapter, the potential of insect cells is thoroughly discussed, from the basic concepts in cell culture to their requirements in terms of up- and down-stream processing as well as the regulatory hurdles.

AB - Since the first reported work on insect cells by Goldschmidt in 1915, more than 600 insect cell lines have been established. With the generation of the first recombinant baculovirus in the late 1980s, the application of insect cell lines for expression of heterologous gene products grew exponentially. Today, the insect cell-baculovirus system is well accepted as a universal manufacturing platform, as demonstrated by the number of approved veterinary and human vaccines. In addition, insect cells are an inexpensive, safe and efficient alternative to human and animal-derived cell lines for studying host-pathogen interactions, cell metabolism, or cellular and humoral immunity, as well as for the production of gene delivery vectors for human gene therapy, for example, modified baculoviruses and mammalian vectors generated via adeno-associated virus. In the longer term, the comprehensive understanding of the regulation and fate of insect stem cells may enable the use of insect cells as a model organism for the development of novel therapies for human diseases. In this chapter, the potential of insect cells is thoroughly discussed, from the basic concepts in cell culture to their requirements in terms of up- and down-stream processing as well as the regulatory hurdles.

KW - Biomedicine and biopharmaceuticals

KW - Bioreactor design

KW - Expression system

KW - Insect cells

KW - Metabolism

KW - Up- and down-stream processing

UR - http://www.scopus.com/inward/record.url?scp=84926950590&partnerID=8YFLogxK

U2 - 10.1002/9783527683321.ch10

DO - 10.1002/9783527683321.ch10

M3 - Chapter

SN - 978-352733547-3

SP - 348

EP - 389

BT - Industrial Scale Suspension Culture of Living Cells

PB - Wiley/Blackwell

ER -

Roldão A, Cox M, Alves P, Carrondo M, Vicente T. Industrial Large Scale of Suspension Culture of Insect Cells. In Industrial Scale Suspension Culture of Living Cells. Wiley/Blackwell. 2014. p. 348-389 https://doi.org/10.1002/9783527683321.ch10